Sofia Hjelmberg

20/20 Vision Centers, Inc. provides lasik surgery services. It offers refractive laser surgery that treats nearsightedness, farsightedness and astigmatism with incisions. It uses technology such as Nidek and Visx Star S3 Laser, Orbscan, and Hansatome Microkeratome. The company is headquartered in Murray, UT.

University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada.

Akademiska Hus AB engages in the ownership, development, and management of properties for colleges and universities where the primary focus is on education and research. The company was founded in 1993 and is headquartered in Gothenburg, Sweden.

The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC.

LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada.

Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du.

American Institute For Medical & Biological Engineering engages in research and development of medical and biological engineering. The private company is based in Washington.

Rimon Therapeutics Ltd. develops and markets pharmaceutical products. The company was founded by Michael May and is headquartered in Mississauga, Canada.

Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada.

The Royal Society of Canada offers educational courses. The non-profit company is based in Ottawa, Canada. The CEO of the Canadian company is Iris Almeida-Cote.

Part of GSK Plc, GlaxoSmithKline AB is a company that manufactures pharmaceutical products. GlaxoSmithKline AB is based in Solna, Sweden. Founded in 1983.

Geistlich Biomaterials Vertriebsgesellschaft mbH provides natural biomaterials for dental, medical and cosmetic surgery use. The company was founded in 1996 and is headquartered in Baden-Baden, Germany.

Ontario Institute for Cancer Research provides research on the prevention, early detection, diagnosis, and treatment of cancer. It offers Innovation programs, like cancer stem cell, innovation in target validation, and smarter imaging, Technology programs, like drug discovery, genome technologies, informatics and bio-computing, imaging translation, and tranformative pathology, and Translation programs. The company was founded by Calvin R. Stiller in December 2005 and is headquartered in Toronto, Canada.

Michael Smith Laboratories provides biotechnology research and training services. It investigates genetics in human, animals and plants, fermentation, bioprocess engineering and bioinformatics. The company is headquartered in Vancouver, Canada.

ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.

Dentalringen AB is a dental supply company based in Västra Frolunda, Sweden. The Swedish company offers a wide range of dental products and services, including cement, structure, pins, accessories, infection and cleaning instruments, bonding glasses, xroting instruments, and more. Today, Dentalringen is a well-established player in the dental market, constantly developing its webshop and services to meet the requirements and needs of its customers. Dental technicians were the main client group when the private company was founded in 2005, but the range was soon expanded to include the needs of tooth clinics.

The Ontario Institute For Regenerative Medicine provides stem cell and regenerative medicine research services. The company was founded by on November 25, 2014 and is headquartered in Toronto, Canada.

ExCellThera, Inc. is a world leader in blood stem cell expansion and rejuvenation. The private company is based in Montréal, Canada. The Canadian company's proprietary molecule, UM171, is the standard for hematopoietic stem cell expansion in cell and gene therapy. UM171 has a first-in-class mechanism of action that expands and rejuvenates HSCs, and counteracts exhaustion from culture and gene modification, which are important limitations in cell and gene therapies. ExCellThera has developed commercial GMP grade UM171, which can be integrated into the manufacturing process of various cell and gene therapy products as a reagent and is supported by a Type II Drug Master File (DMF) filed with the FDA. ExCellThera was founded in 2013 by Peter Zandstra and Guy Sauvageau. Guy Sauvageau has been the CEO since 2013.

Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini.

Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada.

Gamma Biosciences operates as a life sciences tools platform. It focuses on next-generation bioprocessing and technologies for the production of advanced therapies, such as gene and cell-based therapies. The company was founded in 2019 and is headquartered in Menlo Park, CA.

The Centre for the Commercialization of Antibodies & Biologics is a Canadian company that manufactures pharmaceutical products.

Saisei Ventures LLC (Saisei Ventures) is a venture capital firm founded by Jonathan Yeh in 2020. The firm is headquartered in Cambridge, Massachusetts.

ImmuneBridge, Inc. is a biotech company that is developing the next generation of allogeneic cellular medicines to make curative cancer therapies accessible to everyone. The company is based in San Francisco, CA and was founded in 2018 by Jesse Cotari and Peretz Partensky. The company is starting with NK cell-based immunotherapies. The company's proprietary expansion technology amplifies cord blood-derived immune stem cells while maintaining full immune multipotency to create a consistent and abundant cellular source for immunotherapies. ImmuneBridge's scientific approach harnesses this expansion technology along with the unique benefits of umbilical cord blood to enable robust screening and selection for the most potent cancer-fighting cells. Peretz Partensky has been the CEO since 2018.

Omniabio, Inc. is a subsidiary of CCRM and is a contract development and manufacturing organization producing gene-modified cells and viral vectors, compliant with current good manufacturing practices standards. The private company's facility, located at McMaster Innovation Park in Hamilton, Canada, will be the first commercial-scale CDMO dedicated to cell and gene therapies and is expected to be the largest facility of its kind. The company is based in Hamilton, Canada and is supported by the government of Ontario via the Invest Ontario Fund. Omniabio will anchor a biomanufacturing center of excellence and will open in three phases between 2024 and 2026. The CEO of the Canadian company is Mitchel Sivilotti.

Horizon Education LLC offers postsecondary readiness programs to help high school students prepare for graduation and college entrance exams. The company is based in Laguna Beach, CA. The company was founded in 2013 by Dustin Bainbridge and Michelle Sauceda. Dustin Bainbridge has been the CEO since 2013. Horizon Education was acquired by Progress Learning LLC on June 23, 2022.